Financial reports
10-Q
2023 Q3
Quarterly report
30 Oct 23
10-Q
2023 Q2
Quarterly report
31 Jul 23
10-Q
2023 Q1
Quarterly report
2 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
1 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
28 Feb 22
10-Q
2021 Q3
Quarterly report
3 Nov 21
Current reports
8-K
Other Events
7 Mar 24
8-K
Other Events
10 Jan 24
8-K
Biomea Fusion Reports Third Quarter 2023 Financial Results and Corporate Highlights
30 Oct 23
8-K
Biomea Fusion Reports Second Quarter 2023 Financial Results and Corporate Highlights
31 Jul 23
8-K
BMF-219 Induces Complete Responses in Target Acute Myeloid Leukemia (AML) Patient Population
25 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
8-K
Other Events
2 May 23
8-K
Biomea Fusion Reports First Quarter 2023 Financial Results and Corporate Highlights
2 May 23
8-K
Biomea Fusion Announces Proposed Public Offering of Common Stock
3 Apr 23
8-K
Regulation FD Disclosure
28 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
5 Jan 24
424B5
Prospectus supplement for primary offering
30 Mar 23
424B5
Prospectus supplement for primary offering
29 Mar 23
S-8
Registration of securities for employees
4 Jan 23
424B5
Prospectus supplement for primary offering
25 Nov 22
S-3
Shelf registration
14 Oct 22
S-8
Registration of securities for employees
2 Feb 22
S-8
Registration of securities for employees
20 Apr 21
424B4
Prospectus supplement with pricing info
19 Apr 21
S-1MEF
Registration of additional securities for an S-1
15 Apr 21
Other
EFFECT
Notice of effectiveness
25 Oct 22
CORRESP
Correspondence with SEC
20 Oct 22
UPLOAD
Letter from SEC
19 Oct 22
EFFECT
Notice of effectiveness
16 Apr 21
CERT
Certification of approval for exchange listing
15 Apr 21
CORRESP
Correspondence with SEC
15 Apr 21
UPLOAD
Letter from SEC
15 Apr 21
CORRESP
Correspondence with SEC
13 Apr 21
CORRESP
Correspondence with SEC
13 Apr 21
CORRESP
Correspondence with SEC
12 Apr 21
Ownership
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 24
SC 13G/A
Erdtmann Rainer M
12 Feb 24
SC 13G/A
Butler Thomas Andrew
12 Feb 24
SC 13G/A
JANUS HENDERSON GROUP PLC
12 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
SC 13G
Laurion Capital Management LP
8 Feb 24
SC 13G
BlackRock Inc.
29 Jan 24
4
Thomas Andrew Butler
18 Jan 24
4
Rainer M Erdtmann
18 Jan 24
4
Franco Valle
18 Jan 24